Metabolic therapy in children with hypotensive type of autonomic dysfunction syndrome
Journal Title: Здоров`я дитини - Year 2018, Vol 13, Issue 7
Abstract
Background. Trimetabol is a combined appetite stimulant that has cardioprotective, neurotropic and antioxidant effects. The purpose was to evaluate the effectiveness of metabolic therapy with the use of Trimetabol in children with hypotensive type of autonomic dysfunction syndrome. Materials and methods. Forty five children aged 9–17 years with autonomic hypotensive dysfunction were examined. All children were divided into two groups: the main group (n = 30) received Trimetabol, the comparison group (n = 15) — multivitamins. The course of treatment was 1 month. Results. Against the background of treatment with Trimetabol, headache, dizziness, heart pain decreased, appetite, heart rhythm and conduction normalized. Unlike the comparison group, the children of the main group experienced better dynamics of ambulatory blood pressure monitoring (ABPM) and heart rate variability. According to ABPM, average daily systolic blood pressure (SBP) increased from 107.4 ± 1.0 mmHg to 110.8 ± 1.1 mmHg, p < 0.05 (in the comparison group, it has not changed significantly), the time index of hypotension of SBP decreased from 36.3 ± 2.9 % to 25.4 ± 2.6 %, p < 0.01 (in the comparison group — from 40.7 ± 4.7 % to 26.8 ± 4.6 %, p < 0.05). Reduction in total spectrum power was observed in both groups, but in the main group, it was more significant and occurred as a result of a decrease in VLF% (from 75.82 ± 1.63 % to 69.50 ± 1.70 %, p < 0.05), and due to an increase in the specific gravity of LF (from 8.78 ± 0.43 % to 10.20 ± 0.37 %, p < 0.05) and HF% (from 11.31 ± 0.46 % to 13.90 ± 0.80 %, p < 0.05). These data indicate that under the influence of Trimetabol, the central and autonomic regulation circuit activity was redistributed from the decrease in the activity of the central circuits (VLF%) and the relative increase in the activity of autonomic circuits (LF%, HF%). Conclusions. Trimetabol is an effective drug for the treatment of hypotensive type of autonomic dysfunction. The use of Trimetabol improves metabolic processes in the myocardium, normalizes the autonomic regulation of the cardiac rhythm and blood pressure and is safe for adolescents.
Authors and Affiliations
Yu. V. Marushko, T. V. Hyshchak
Keywords
Related Articles
- EP ID EP423722
- DOI 10.22141/2224-0551.13.7.2018.148920
- Views 69
- Downloads 0
Evaluating the Diagnostic Value of the Tissue Hypoxia, Membrane Destruction and Undifferentiated Connective Tissue Dysplasia Markers in Young Children with Vesicouretheral Reflux
Introduction. The issue of congenital urinary defects in young children becomes more apparent due to the annual increase in the number of patients. One of the most frequent pathologies is vesicoureteral reflux. Today, th...
Didactic Approaches to the Teaching Pharmacotherapy in Pediatrics
Clinical reasoning formation is impossible without correct organization of the teaching process. Aim of the study was to indicate didactic approaches to teaching pharmacotherapy to students in pediatrics, to define metho...
Venous malformations in children: controversies of the diagnosis and treatment
Background. The characteristics of venous malformations are the progressive course, high risk of complications and unstable results of treatment. The purpose of the study is to determine the informative diagnostic method...
The place of endogenous antimicrobial peptides in the pathogenetic mechanisms of the development of community-acquired pneumonia caused by Streptococcus pneumoniae among infants
A comprehensive survey was carried out in 30 children with community-acquired pneumonia aged 2 months to 3 years old, among them in 18 children the disease was caused by Streptococcus pneumoniae, and in the remaining 12...
Cough: Differential Approaches to Treatment
The article discusses the main differential approaches to treatment of cough, depending on its characteristics and causes.